Viewing Study NCT03230734

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2026-02-07 @ 5:23 AM
Study NCT ID: NCT03230734
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-09-27
First Post: 2017-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration-resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None prostate cancer View
None castration-resistant prostate cancer View
None metastatic prostate cancer View
None bone only metastatic prostate cancer View
None radium-223 View
None Docetaxel View